Miguel Ángel Tejada

No ORCID on file · 2 papers in corpus · active 2024-2025

Study types

  • meta-analysis 1
  • other 1

Condition tags

  • chronic_pelvic_pain 1
other 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1546059
meta-analysis 2024
European journal of pharmacology ·doi:10.1016/j.ejphar.2024.177052

BACKGROUND: P2X3 and P2X2/3 receptors are promising therapeutic targets for pain treatment and selective inhibitors are under evaluation in ongoing clinical trials. Here we aim to consolidate and quantitatively evaluate the preclinical evid…